Virus integration site detection method and device, storage medium and electronic equipment
Through liquid phase probe hybridization capture technology and high-throughput sequencing, the complexity and false negative problems of virus integration site detection in the existing technology are solved, and accurate integration site detection of multiple viral vectors is achieved, and detection is improved accuracy and efficiency.
Patent Information
- Application Number
- CN202411095524.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-09
- Publication Date
- 2024-12-06
AI Technical Summary
Existing methods for detecting viral integration site are complex and prone to false negative results, especially in the case of sequence mutation, making it difficult to accurately capture the integration site.
Using liquid phase probe hybridization capture technology, by obtaining sample DNA and performing interruption, repair and PCR amplification, probe sets for different viral vectors are designed for liquid phase hybridization and sequencing, combining high-throughput sequencing and biological information analysis. Analyze the integration situation and set threshold filtering to obtain virus integration site information.
It improves the uniformity and accuracy of capture, reduces false negative results caused by sequence variation, and can detect multiple samples and multiple integration types in a short time, with a detection accuracy of 100%.
Smart Images

Figure BDA0004988404950000251 
Figure BDA0004988404950000261 
Figure BDA0004988404950000262
Abstract
Description
Technical Field
[0001] The present invention relates to the field of molecular biology and gene detection technology, and in particular to a method, device, storage medium and electronic equipment for detecting virus integration sites. Background Art
[0002] Cellular and Gene Therapy (CGT) refers to the process of transferring exogenous nucleic acids (DNA, RNA, etc.) into specific target cells of patients (both in vivo and in vitro), modifying the expression of individual genes or repairing abnormal genes through gene addition, gene correction, gene silencing, etc., to achieve the goal of curing or slowing down the disease. For example, chimeric antigen receptor T cell therapy (CAR-T) is an immune cell therapy that uses a lentiviral vector to transfer a genetic material with a specific antigen recognition domain and T cell activation information into T cells, giving them the ability to specifically attack tumor cells. With the rapid development of biotechnologies such as gene delivery vectors and gene editing, the clinical application of gene therapy products has continued to make new progress. At the same time, agencies such as the U.S. FDA (Food and Drug Administration) and the European Medicines Agency (EMA) have formulated a series of regulations and guidelines to standardize the research and development, testing and marketing of such products. In addition, the Drug Approval Center of the my country Food and Drug Administration has also issued a series of guidelines based on product characteristics. For example, the "Non-clinical Research and Technical Guidelines for Genetically Modified Cell Therapy Products (Trial)" states that "gene and cell therapy drugs transfer genetic material into host cells or integrate into the host genome or edit the host genome, which poses a potential risk of genotoxicity. It is necessary to analyze the characteristics of genomic changes and assess the relevant potential risks." The "Technical Guidelines for Non-clinical Research and Evaluation of Gene Therapy Products (Trial)" states that "it is necessary to evaluate the possibility of gene therapy products integrating into the genome based on the characteristics of the gene therapy products, the specific indications of the products, the existing information of the vectors, the sequence structure of the introduced genes, etc., and determine whether additional genotoxicity studies are needed, such as evaluating the genotoxicity risks caused by insertion mutations (insertion sites, insertion copy numbers, etc.)." The "Technical Guidelines for Pharmaceutical Research and Evaluation of In Vivo Gene Therapy Products (Trial)" states that "analyze the integration mode of the vector in the genome and the distribution trend of the integration sites, and evaluate the risk of gene mutation, gene inactivation / activation, or cell carcinogenesis caused by its insertion." Accurate detection of viral integration sites can reduce the safety risks of biological products and promote the application and development of cell and gene therapy related products.
[0003] In the past, the commonly used integration site identification was based on LAM-PCR and its derivative technologies, which used linear amplification and magnetic bead separation to enrich the nucleic acid fragments at the junction of the vector (known sequence) and the genome, followed by double-stranded synthesis, restriction enzyme digestion, nested PCR, adapter ligation and other steps to build a library and perform high-throughput sequencing to identify the integration site. However, since LAM-PCR requires specific primers to be designed for different viral vector types for amplification to determine the integration of the vector; the multi-step PCR process and the need to use restriction enzyme digestion increase the complexity of the operation; there may be amplification bias for certain genomic regions; vector LTR variation may cause primer detachment, etc. Summary of the invention
[0004] In view of this, the technical problem to be solved by the present invention is to provide a method, device, storage medium and electronic device for detecting viral integration sites. The present invention provides a method for detecting integration sites using liquid phase probe hybridization capture technology, which improves the uniformity of capture and reduces false negatives caused by primer detachment due to sequence variation.
[0005] The present invention provides a method for detecting virus integration sites, comprising the following steps:
[0006] Step 1, obtaining sample DNA and shearing it to a fragment with a main peak of 200 to 500 bp, and obtaining a pre-library after end repair, adding adapters and PCR amplification of the fragment;
[0007] Step 2: obtaining the sequence of the viral delivery vector, obtaining a target sequence group after sequence truncation, alignment, removal of abnormal sequences and deduplication, and designing and synthesizing a probe group for detecting viral integration sites based on the target sequence group;
[0008] Step 3, taking the pre-library and the probe set for liquid phase hybridization and then sequencing on a machine;
[0009] Step 4: Compare the sequencing results with the host genome and the target sequence group respectively, and perform integration analysis, integration ratio statistics and detection threshold filtering based on the comparison results to obtain information on the virus integration site.
[0010] Compared with the prior art, the method for detecting viral integration sites provided by the present invention can capture integration sites for different viral vectors by designing different probes. Moreover, since the probe capture technology has the advantages of high error tolerance for capturing sequences, uniform capture of integration sites, and capture of regions that are not easily PCR amplified, compared with the traditional LAM-PCR technology, the uniformity of capture is further improved, and false negatives caused by primer detachment due to sequence variation are reduced, thereby obtaining a more accurate technical effect.
[0011] In some embodiments, the virus in the viral delivery vector comprises at least one of a lentivirus, an adenovirus, an adeno-associated virus, a retrovirus, a murine leukemia virus, and an avian leukemia virus.
[0012] In some embodiments, in step 2, the sequence of the viral delivery vector includes the ITR sequence and / or LTR sequence of the viral delivery vector.
[0013] Compared with other sequences, the special structure formed by LTR and ITR of viral delivery vectors helps maintain stability during the integration process, and both usually contain integration-related signals and specific recognition elements. The stable structure can promote the interaction between integrase and DNA, making the integration reaction more efficient and thus obtaining more accurate technical effects.
[0014] In some embodiments, in step 2,
[0015] The sequence of the viral delivery vector is extracted using bedtools software according to the LTR and ITR position information in the feature information file;
[0016] The sequences after sequence truncation were aligned using the mafft software and visualized based on MEGA to evaluate the conservation of the sequences and eliminate the abnormal sequences.
[0017] In some embodiments, in step 3, the liquid phase hybridization includes library hybridization, library capture and elution to obtain a hybrid capture library, and the hybrid capture library is amplified by PCR, purified and quantified before sequencing.
[0018] In some specific embodiments, in the liquid phase hybridization, the number of samples in the pre-library is an integer from 1 to 6.
[0019] Experiments show that the detection method of the present invention can make judgments on multiple samples and multiple integration types in one batch, and can complete the analysis of the integration status of multiple samples in a short period of time, thereby obtaining more accurate technical effects.
[0020] In some embodiments, in step 4, the sequencing results are subjected to data quality control before the comparison.
[0021] In some embodiments, in step 4, the result of the alignment includes the number of reads after quality control, the number of breakpoint support reads aligned to the target sequence group, and the number of chimeric reads aligned to the host genome and the target sequence group;
[0022] The detection threshold is determined according to the following ① and / or ②:
[0023] ①, the ratio of the number of breakpoint support reads to the number of reads after quality control;
[0024] ②. The ratio of the number of breakpoint supporting reads to the number of chimeric reads.
[0025] In some specific embodiments, the viral delivery vector comprises at least one of an adeno-associated viral delivery vector, a lentiviral delivery vector, and a retroviral delivery vector.
[0026] The current mainstream viral delivery vector systems include lentivirus (LV), retrovirus (Retrovirus), adeno-associated virus (AAV) vectors, etc. First, lentivirus vectors are the most mature and widely used type of viral vectors, especially in the field of immune cell therapy, and this system completely retains the original advantages of high expression efficiency and long expression time of retroviruses, and has greatly improved its infection ability, but it also retains the instability of random insertion. Second, γ-retrovirus (such as murine leukemia virus) is also a commonly used delivery method. Because its genome is relatively simple and the integration site is relatively stable, it is often used to transduce hematopoietic stem cells, neural stem cells and other cell types. Third, adeno-associated virus AAV vectors, as a new type of viral vector delivery technology, have also been used in many approved gene therapy products. Compared with the previous two viral vectors, this virus usually exists in the cell nucleus in the form of exogenous DNA, has low integration risk, higher safety, but small vector capacity, low expression level and other characteristics, but gene editing usually requires the introduction of specific changes in the cell genome, and a higher integration rate is required to ensure the stability of the edited gene. Compared with gene therapy products, the probability of vector integration into the genome when gene editing products are delivered with AAV is relatively high. Since both lentiviral and retroviral vectors can be integrated into the host genome, and the integration site is uncertain. According to previous reports, adeno-associated virus vectors also have a certain probability of genome integration. However, uncertain integration sites may cause safety issues such as activation of proto-oncogenes and inactivation of tumor suppressor genes. Therefore, the present invention uses adeno-associated virus delivery vectors, lentiviral delivery vectors and retroviral delivery vectors as target sequences for probe design, which can capture integration sites for different viral vectors, and can comprehensively detect the integration of multiple viral delivery vector sequences, thereby obtaining more accurate technical effects.
[0027] In some specific embodiments, the target sequence group includes at least one of the adeno-associated virus delivery vector target sequence group, the lentivirus delivery vector target sequence group, and the retrovirus delivery vector target sequence group, wherein:
[0028] The adeno-associated virus delivery vector target sequence group has at least one of the nucleotide sequences shown in SEQ ID NOs: 1 to 13;
[0029] The lentiviral delivery vector target sequence group has at least one of the nucleotide sequences shown in SEQ ID NOs: 14 to 40;
[0030] The target sequence group of the retroviral delivery vector has at least one of the nucleotide sequences shown in SEQ ID NOs: 41-89.
[0031] In some specific embodiments, the detection threshold is set as:
[0032] The ratio of the number of breakpoint support reads to the number of reads after quality control is greater than 5e-6; and
[0033] The ratio of the breakpoint supporting reads number to the chimeric reads number is greater than 0.01.
[0034] The present invention also provides an integration site detection device, comprising:
[0035] Data acquisition module: used to obtain sample sequencing data;
[0036] Analysis module: analyzing and obtaining viral integration sites according to the described method;
[0037] Output module: used to output and display the results obtained by the analysis module.
[0038] The present invention provides a storage medium, which includes a stored program, wherein the program executes the method for detecting virus integration sites when executed by a processor.
[0039] The present invention provides an electronic device, comprising a processor, a memory and a bus, wherein the processor and the memory are connected via the bus;
[0040] The memory is used to store programs, and the processor is used to run programs, wherein the program executes the method for detecting virus integration sites when the processor runs the program.
[0041] The present invention provides a method, device, storage medium and electronic device for detecting viral integration sites. After the present invention designs probes in batches for integration border sequences of all lentivirus, retrovirus and adeno-associated virus vectors, they can be used to identify integration sites of all the above-mentioned vector types, and can capture and identify integration sites of multiple samples at the same time, thereby significantly reducing experimental costs and cycles, and improving detection sample throughput and accuracy.
[0042] Compared with the prior art, the present invention has the following advantages:
[0043] 1. High throughput: The probe capture technology of the present invention can be used to determine multiple samples and multiple integration types in one batch, and combined with high-throughput sequencing technology and bioinformatics analysis solutions, it can complete the analysis of the integration status of multiple samples in a short period of time.
[0044] 2. High universality: The bioinformatics analysis process in the present invention can be applied to high-throughput sequencing analysis of different integration site detection technologies, such as LAM-PCR and WGS sequencing.
[0045] 3. The experimental and analytical processes are simple and easy to operate: In the experimental process of the present invention, one round of probe capture is performed after the sample library is built to complete the enrichment of the integration site region; the analytical process is simple to deploy and easy to use. After being deployed on the computing server, it can be quickly applied to relevant data detection, thereby significantly reducing the experimental cost and cycle.
[0046] 4. High sensitivity: The detection method of the present invention is used to detect samples, and the detection accuracy reaches 100%. BRIEF DESCRIPTION OF THE DRAWINGS
[0047] Figure 1 The whole process diagram of identifying integration sites by probe capture technology is shown;
[0048] Figure 2 The following is a flow chart showing the probe design process;
[0049] Figure 3 Shows the flow chart of bioinformatics analysis;
[0050] Figure 4 Shows the detection results of the WHO sample threshold combination. DETAILED DESCRIPTION
[0051] The present invention provides a method, device, storage medium and electronic device for detecting viral integration sites. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve it. It should be particularly noted that all similar substitutions and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The methods and applications of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications of this article without departing from the content, spirit and scope of the present invention to implement and apply the technology of the present invention.
[0052] The test materials used in the present invention are all common commercial products and can be purchased in the market. The present invention is further described below in conjunction with the embodiments.
[0053] Example 1
[0054] The experimental scheme and ideas of the present invention include 4 main modules: Figure 1As shown, they are probe design module, wet experiment process module, dry experiment process module, and sample test result module.
[0055] 1Probe design module
[0056] In order to meet the needs of various viral vector integration site detection as much as possible, we downloaded three viral delivery vector sequences and their corresponding features from NCBI and Addgene websites, including lentivirus (LV), retrovirus (Retrovirus), adeno-associated virus (AAV) vectors, etc. The design flow chart is shown in Figure 2 .
[0057] (1) Search the Addgene website using the following keyword combinations: a. "5'LTR" and "Lentivirus"; b. "5'LTR" and "retrovirus"; c. "AAV" to obtain all sequence and feature information. On the NCBI website, download all sequence information corresponding to "Taxonomy ID: 29278" and manually filter out vector sequences and features information related to "Lenti", "Retrovirus", and "AAV".
[0058] (2) Using bedtools software, the corresponding target sequence was intercepted according to the LTR and ITR position information in the feature information file.
[0059] (3) The target fragment sequences were multiplexed according to the three vector types using the MAFFT software, visualized based on MEGA, and the conservation of the sequences was evaluated and abnormal sequences were eliminated.
[0060] (4) De-duplicate the screened sequences for use in probe design.
[0061] (5) Finally, the 89 sequences after deduplication were used for probe design. The total length of the probe design region was 31.60 kb, and the probe target sequence was as follows:
[0062] (1) ITR sequence of AAV vector:
[0063] SEQ ID NO: 1:
[0064] ggaacccctagtgatggagttggccactccctctctgcgcgctcgctcgctcactgaggccgggcgaccaaa ggtcgcccgacgcccgggctttgcccgggcggcctcagtgagcgagcgagcgcgcagctgcctgcagg
[0065] SEQ ID NO:2:
[0066] ctgcaggcagctgcgcgctcgctcgctcactgaggccgcccgggcgtcgggcgacctttggtcgcccggcc tcagtgagcgagcgagcgcgcagagagggagtggccaactccatcactaggggttcct
[0067] SEQ ID NO:3:
[0068] tgcgcgctcgctcgctcactgaggccgcccgggcaaagcccgggcgtcgggcgacctttggtcgcccggcc tcagtgagcgagcgagcgcgcagagagggagtggccaactccatcactaggggttcct
[0069] SEQ ID NO:4:
[0070] ggaacccctagtgatggagttggccactccctctctgcgcgctcgctcgctcactgaggccgggcgaccaaa ggtcgcccgacgcccgggctttgcccgggcggcctcagtgagcgagcgagcgcgcag
[0071] SEQ ID NO:5:
[0072] ggaacccctagtgatggagttggccactccctctctgcgcgctcgctcgctcactgaggccgggcgaccaaa ggtcgcccgacgcccgggcggcctcagtgagcgagcgagcgcgcagctgcctgcagg
[0073] SEQ ID NO:6:
[0074] ctgcaggcagctgcgcgctcgctcgctcactgaggccgcccgggcaaagcccgggcgtcgggcgacctttg gtcgcccggcctcagtgagcgagcgagcgcgcagagagggagtggccaactccatcactaggggttcct
[0075] SEQ ID NO:7:
[0076] atctcaataatataccttattttggattgaagccaatatgataatgagggggtggagtttgtgacgtggcgcgggg cgtgggaacggggcgggtgacgtag
[0077] SEQ ID NO:8:
[0078] tacgtcaccccccgttcccacgccccgcgccacgtcacaaactccaccccctcattatcatattggcttcaatcc aaaataaggtatattattgatgatg
[0079] SEQ ID NO:9:
[0080] tgcgcgctcgctcgctcactgaggccgcccgggcaaagcccgggcgtcgggcgaccaaaggtcgcccggc ctcagtgagcgagcgagcgcgcagagagggagtggccaactccatcactaggggttcct
[0081] SEQ ID NO:10:
[0082] ggaacccctagtgatggagttggccactccctctctgcgcgctcgctcgctcactgaggccgggcgaccaaa ggtcgsccgacgcccgggctttgcccgggcggcctcagtgagcgagcgagcgcgcag
[0083] SEQ ID NO:11:
[0084] ggaacccctagtgatggagttggccactccctctctgcgcgctcgctcgctcactgaggccgggcgaccaaa ggtcgcccgacgcccgggctttgcccgagcggcctcagtgagcgagcgagcgcgcagctgcctgcagg
[0085] SEQ ID NO:12:
[0086] gcagctgcgcgctcgctcgctcactgaggccgcccgggcgtcgggcgacctttggtcgcccggcctcagtg agcgagcgagcgcgcagagagggagtggccaactccatcactaggggttcct
[0087] SEQ ID NO:13:
[0088] cctagtgatggagttggccactccctctctgcgcgctcgctcgctcactgaggccgggcgaccaaaggtcgcc cgacgcccgggctttgcccgggcggcctcagtgagcgagcgagcgcgcagctgcctgcaggggcgcc
[0089] (2) Probe design sequence of lentiviral vector
[0090] SEQ ID NO:14:
[0091] atgtagtcttatgcaatactcttgtagtcttgcaacatggtaacgatgagttagcaacatgccttacaaggagagaaaaagcaccgtgcatgccgattggtggaagtaaggtggtacgatcgtgccttattaggaaggcaacagacgggtctgacatggattggacgaaccactgaattgccgcattgcagagatattgtatttaagtgcctagctcgatacataaacgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0092] SEQ ID NO:15:
[0093] caccgtgcatgccgattggtggaagtaaggtggtacgatcgtgccttattaggaaggcaacagacgggtctgacatggattggacgaaccactgaattgccgcattgcagagatattgtatttaagtgcctagctcgatacataaacgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0094] SEQ ID NO:16:
[0095] ctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0096] SEQ ID NO:17:
[0097] ctggaagggctaattcactcccaacgaagacaagactgctttttgcttgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0098] SEQ ID NO:18:
[0099] gctagagattttccacactgactaaaagggtctgagggatctctagttaccagagtcacacaacagacgggcacacactacttgaagcactcaaggcaaactttattgaggcttaagcagtgggttccctagttagccagagagctcccaggctcagatctggtctaaccagagaaaccc
[0100] SEQ ID NO:19:
[0101] gctagagattttccacactgactaaaagggtctgagggatctctagttaccagagtcacacaacagacgggcacacactacttgaagcactcaaggcaaactttattgaggcttaagcagtgggttccctagttagccagagagctcccaggctcagatctggtctaaccagagaaacccagtacaagcaaaaagcagatcttgtcttcgttgggagtgaattagcccttccaSEQ ID NO:20:
[0102] ggaagggctaattcactcccaaagaagacaagatatccttgatctgtggatctaccacacacaaggctacttccctgattagcagaactacacaccagggccaggggtcagatatccactgacctttggatggtgctacaagctagtaccagttgagccagataaggtagaagaggccaataaaggagagaacaccagcttgttacaccctgtgagcctgcatgggatggatgacccggagagagaagtgttagagtggaggtttgacagccgcctagcatttcatcacgtggcccgagagctgcatccggagtacttcaagaactgctgatatcgagcttgctacaagggactttccgctggggactttccagggaggcgtggcctgggcgggactggggagtggcgagccctcagatcctgcatataagcagctgctttttgcctgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0103] SEQ ID NO:21:
[0104] ggaagggctaattcactcccaacgaaaataagatctgctttttgcttgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0105] SEQ ID NO:22:
[0106] ggaagggctaattcactcccaacgaagacaagatatccttgatctgtggatctaccacacacaaggctacttccctgattggcagaactacacaccagggccagggatcagatatccactgacctttggatggtgctacaagctagtaccagttgagcaagagaaggtagaagaagccaatgaaggagagaacacccgcttgttacaccctgtgagcctgcatgggatggatgacccggagagagaagtattagagtggaggtttgacagccgcctagcatttcatcacatggcccgagagctgcatccggactgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagcag
[0107] SEQ ID NO:23:
[0108] ggaagggctaattcactcccaacgaagacaagatctgctttttgcttgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0109] SEQ ID NO:24:
[0110] ggaagggctaattcactcccaacgaagacaagatctgctttttgcttgtactgggtttctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagtttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0111] SEQ ID NO:25:
[0112] ggaagggctacgtaactcccaacgaagacaagatctgctttttgcttgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0113] SEQ ID NO:26:
[0114] ggaagggctagctcactcccaacgaagacaagatctgctttttgcttgtactggatctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0115] SEQ ID NO:27:
[0116] ggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagc
[0117] SEQ ID NO:28:
[0118] ggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0119] SEQ ID NO:29:
[0120] ggtgatgcggttttggcagtacatcaatgggcgtggatagcggtttgactcacggggatttccaagtctccaccccattgacgtcaatgggagtttgttttggcaccaaaatcaacgggactttccaaaatgtcgtaacaactccgccccattgacgcaaatgggcggtaggcgtgtacggtgggaggtctatataagcagcgcgttttgcctgtactgggtctctctggttagaccaga
[0121] SEQ ID NO:30:
[0122] ggtttctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagtttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagc
[0123] SEQ ID NO:31:
[0124] ggtttctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagtttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0125] SEQ ID NO:32:
[0126] gtctctctggttagaccagaaaggagcattggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0127] SEQ ID NO:33:
[0128] gtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgctcaaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0129] SEQ ID NO:34:
[0130] gtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0131] SEQ ID NO:35:
[0132] gtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaattctctagca
[0133] SEQ ID NO:36:
[0134] gtggggtttttatgaggggttttatacaattgggcactcagattctgcggtctgagtcccttctctgctgggctgaa aaggcctttgtaataaatataattctctactcagtccctgtctctagtttgtctgttcgagatcctacag
[0135] SEQ ID NO:37:
[0136] gtttctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagtttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0137] SEQ ID NO:38:
[0138] tggaagggctaattcactcccaacgaagacaagatctgctttttgcttgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagca
[0139] SEQ ID NO:39:
[0140] tggaagggctgctgaattcactcccaacgaagacaagatatccactgaccgcacgcctgcaggctagccctcagatcctgcatataagcagctgctttttgcctgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagcag
[0141] SEQ ID NO:40:
[0142] tgtactgggtctctctggttagaccagatctgagcctgggagctctctggctaactagggaacccactgcttaagcctcaataaagcttgccttgagtgcttcaagtagtgtgtgcccgtctgttgtgtgactctggtaactagagatccctcagacccttttagtcagtgtggaaaatctctagcag
[0143] (3) Retrovirus design probe sequence
[0144] SEQ ID NO:41:
[0145] aacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccgctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgttctcaataaaccctcttgcagttgcatccgactcgtggtctcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtctttcatt
[0146] SEQ ID NO:42:
[0147] aacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcg
[0148] SEQ ID NO:43:
[0149] aacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgatagactgcgtcg
[0150] SEQ ID NO:44:
[0151] aacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggactcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtctttcat
[0152] SEQ ID NO:45:
[0153] aacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggactcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtctttcatt
[0154] SEQ ID NO:46:
[0155] aacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggactcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtctttcat
[0156] SEQ ID NO:47:
[0157] aataaaagagcccacaacccctcactcggcgcgccagtcttccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccacgacgggggtctttcatt
[0158] SEQ ID NO:48:
[0159] aatgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagaaaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcat
[0160] SEQ ID NO:49:
[0161] aatgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagaaaagttcagatcaaggtcaggaacagatggaacagggtcgcgtcccgcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgca
[0162] SEQ ID NO:50:
[0163] aatgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcat
[0164] SEQ ID NO:51:
[0165] aatgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttggaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0166] SEQ ID NO:52:
[0167] agctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0168] SEQ ID NO:53:
[0169] atgaaagaccccacctgtaggtttggcaagctagctgcagtaacgccattttgcaaggcatggaaaaataccaaaccaagaatagagaagttcagatcaagggcgggtacatgaaaatagctaacgttgggccaaacaggatatctgcggtgagcagtttcggccccggcccggggccaagaacagatggtcaccgcagtttcggccccggcccgaggccaagaacagatggtccccagatatggcccaaccctcagcagtttcttaagacccatcagatgtttccaggctcccccaaggacctgaaatgaccctgcgccttatttgaattaaccaatcagcctgcttctcgcttctgttcgcgcgcttctgcttcccgagctctataaaagagctcacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggactcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtctt
[0170] SEQ ID NO:54:
[0171] atgaaagaccccacctgtaggtttggcaagctagctgcagtaacggccattttgcaaggcatggaaaaataccaaaccaagaatagagaagttcagatcaagggcgggtacatgaaaatagctaacgttgggccaaacaggatatctgcggtgagcagtttcggccccggcccggggccaagaacagatggtcaccgcagtttcggccccggcccgaggccaagaacagatggtccccagatatggcccaaccctcagcagtttcttaagacccatcagatgtttccaggctcccccaaggacctgaaatgaccctgcgccttatttgaattaaccaatcagcctgcttctcgcttctgttcgcgcgcttctgcttcccgagctctataaaagagctcacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggactcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtct
[0172] SEQ ID NO:55:
[0173] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagaaaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0174] SEQ ID NO:56:
[0175] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgca
[0176] SEQ ID NO:57:
[0177] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttca
[0178] SEQ ID NO:58:
[0179] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0180] SEQ ID NO:59:
[0181] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagggtcgaccctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0182] SEQ ID NO:60:
[0183] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaatacataactgagaatagagaagttcagatcaaggttaggaacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccgctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgttctcaataaaccctcttgcagttgcatccgactcgtggtctcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtctttcatt
[0184] SEQ ID NO:61:
[0185] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaatacataactgagaatagagaagttcagatcaaggttaggaacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggactcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtctttcatt
[0186] SEQ ID NO:62:
[0187] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaatacataactgagaatagagaagttcagatcaaggttaggaacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagttggaacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgatagactgcgtcgcccgggtacccgtgttctcaataaaccctcttgcagttgcatccgactcgtggtctcgctgttccttgggagggtctcctctgagtgattgactgcccacctcgggggtctttcatt
[0188] SEQ ID NO:63:
[0189] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttggaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttca
[0190] SEQ ID NO:64:
[0191] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttggaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttca
[0192] SEQ ID NO:65:
[0193] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttggaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcat
[0194] SEQ ID NO:66:
[0195] atgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttggaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0196] SEQ ID NO:67:
[0197] atgaaagacccccgaggtgggcagtcaatcaatctgaggagaccctcccaaggatcagcgagtccacgattcggatgcaaacagcaagaggctttattgggaatacgggtacccgggcgacgcagtctatcggaggactggcgcgccgagtgaggggttgtgggctcttttattgagctcggggagcagaagcgcgcgaacagaagcgagaagcgaactgattggttagttcaaataaggcacagggtcatttcaggtccttggggcaccctggaaacatctgatggttctctagaaactgctgagggcgggaccgcatctggggaccatctgttcttggccctgagccggggcaggaactgcttaccacagatatcctgtttggcccatattctgctgtctctctgttcctaaccttgatctgaacttctctattctcagttatgtattttccatgccttgcaaaatggcgttacttaagctagcttgccaaacctacaggtggggtctttcatt
[0198] SEQ ID NO:68:
[0199] atgaaagacccccgctgacgggtagtcaatcactcagaggagaccctcccaaggaacagcgagaccacaagtcggatgcaactgcaagagggtttattggatacacgggtacccgggcgactcagtcaatcggaggactggcgccccgagtgaggggttgtgggctcttttattgagctcggggagcagaagcgcgcgaacagaagcgagaagcgaactgattggttagttcaaataaggcacagggtcatttcaggtccttggggcaccctggaaacatctgatggttctctagagcactgttccatctgttcctgaccttgatctgaacttctctattctcagttatgtatttttccatgccttgcaaaatggcgttacttaagctagcttgccaaacctacaggtggggtctttcatt
[0200] SEQ ID NO:69:
[0201] atgaaagacccccgtcgtgggtagtcaatcactcagaggagaccctcccaaggaacagcgagaccacgattcggatgcaaacagcaagaggctttattgggaatacgggtacccgggcgacgcagtctatcggaagactggcgcgccgagtgaggggttgtgggctcttttattgagctcggagagcggaagcgcgcgaacagaagcgagaagcgaactgattggttagttcaaataaggtacagggtcattttcaggtccttggggcaccctggaaacatctgatgattcactagaaactgctgagggctggaccgcatctggggaccatctgttcttggccccgagccggggcaggaactgcttaccacagatatcctgtttggcccatcactcagctgtctcatctgttcttggccctgagccggggcaggaaccgcttaccacagatatcctgtttggtattcagctgtttctttgttcctgaccttgatctgaacttttctattctcagttatgtatttttccatgccttgcaaagtggcgttacttaagctagcttgccacctacgggtggggtctttcaaa
[0202] SEQ ID NO:70:
[0203] ccgcgttacataacttacggtaaatggcccgcctggctgaccgcccaacgacccccgcccattgacgtcaataatgacgtatgttcccatagtaacgccaatagggactttccattgacgtcaatgggtggagtatttacggtaaactgcccacttggcagtacatcaagtgtatcatatgccaagtacgccccctattgacgtcaatgacggtaaatggcccgctctggcattatgcccagtacatgaccttatgggactttcctacttggcagtacatctacgtattagtcatcgctattaccatggtgatgcggttttggcagtacatcaatgggcgtggatagcggtttgactcacggggatttccaagtctccaccccattgacgtcaatgggagtttgttttggcaccaaaatcaacgggactttccaaaatgtcgtaacaactccgccccattgacgcaaatgggcggtaggcgtgtacggtgggaggtctatataagcagagctcaataaaagagcccacaacccctcactcggcgcgccagtcttccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccacgacgggggtctttcatttgggggctcgtccgggatttggagacccctgcccaggga
[0204] SEQ ID NO:71:
[0205] cgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0206] SEQ ID NO:72:
[0207] ctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcat
[0208] SEQ ID NO:73:
[0209] ctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcttccgatagactgcgtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcat
[0210] SEQ ID NO:74:
[0211] ctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcat
[0212] SEQ ID NO:75:
[0213] ctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagagaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttca
[0214] SEQ ID NO:76:
[0215] ctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttc
[0216] SEQ ID NO:77:
[0217] gaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagaaaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0218] SEQ ID NO:78:
[0219] gaaagacccccgctgacgggtagtcaatcactcagaggagaccctcccaaggaacagcgagaccacaagtcggatgcaactgcaagagggtttattggatacacgggtacccgggcgactcagtcaatcggaggactggcgcgccgagtgaggggttgtgggctcttttattgagctcggggagcagaagcgcgcgaacagaagcgagaagcgaactgattggttagttcaaataaggcacagggtcatttcaggtccttggggcaccctggaaacatctgatggttctctagaaactgctgagggctggaccgcatctggggaccatctgttcttggccctgagccggggcaggaactgcttaccacagatatcctgtttggcccatattcagctgttccatctgttcttggccctgagccggggcaggaactgcttaccacagatatcctgtttggcccatattcagctgttccatctgttcctgaccttgatctgaacttctctattctcagttatgtatttttccatgccttgcaaaatggcgttacttaagctagcttgccaaacctacaggtggggtctttca
[0220] SEQ ID NO:79:
[0221] gaaagacccccgctgacgggtagtcaatcactcagaggagaccctcccaaggaacagcgagaccacaagtcggatgcaactgcaagagggtttattggatacacgggtacccgggcgactcagtcaatcggaggactggcgcgccgagtgaggggttgtgggctcttttattgagctcggggagcagaagcgcgcgaacagaagcgagaagcgaactgattggttagttcaaataaggcacagggtcatttcaggtccttggggcaccctggaaacatctgatggttctctagctgttccatctgttcctgaccttgatcgggatcgaattccatgcatcatatccatcgcaatcgcatccccattcaattcgcatcgcatatccgatgccgatatggcatcgcgattgccatccaatccgatcccgatctgaacttctctattctcagttatgtatttttccatgccttgcaaaatggcgttacttaagctagcttgccaaacctacaggtggggtctttca
[0222] SEQ ID NO:80:
[0223] gaacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggactcgctgatccttgggagggtctcctcagattgattgactgcccacctcgggggtctttcat
[0224] SEQ ID NO:81:
[0225] gaagaataaaaaattactggcctcttgtgagaacatgaactttcacctcggagcccaccccctcccatctggaaaacatacttgagaaaaacattttctggaacaaccacagaatgtttcaacaggccagatgtattgccaaacacaggatatgactctttggttgagtaaatttgtggttgttaaacttcccctattccctccccattccccctcccagtttgtggttttttcctttaaaagcttgtgaaaaatttgagtcgtcgtcgagactcctctaccctgtgcaaaggtgtatgagtttcgaccccagagctctgtgtgctttctgttgctgctttatttcgaccccagagctctggtctgtgtgctttcatgtcgctgctttattaaatcttaccttctacattttatgtatggtctcagtgtcttcttgggtacgcggctgtcccgggacttgagtgtctgagtgagggtcttccctcgagggtctttcatttggtacatgggccgggaattcgagaatctttcatttggtgcattggccgggaattcgaaaatctttca
[0226] SEQ ID NO:82:
[0227] tagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcatt
[0228] SEQ ID NO:83:
[0229] tgaaagaccccacccgtaggtggcaagctagcttaagtaacgccactttgcaaggcatggaaaaatacataactgagaatagaaaagttcagatcaaggtcaggaacaaagaaacagctgaataccaaacaggatatctgtggtaagcggttcctgccccggctcagggccaagaacagatgagacagctgagtgatgggccaaacaggatatctgtggtaagcagttcctgccccggctcggggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagtgaatcatcagatgtttccagggtgccccaaggacctgaaaatgaccctgtaccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttccgctctccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcttccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccacgacgggggtctttcat
[0230] SEQ ID NO:84:
[0231] tgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaatacataactgagaatagagaagttcagatcaaggttaggaacagagagacagcagaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtcccgccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgatagactgcgtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttcat
[0232] SEQ ID NO:85:
[0233] tgaaagacccccgctgacgggtagtcaatcactcagaggagaccctcccaaggaacagcgagaccacaagtcggatgcaactgcaagagggtttattggatacacgggtacccgggcgacgcagtctatcggaggactggcgcgccgagtgaggggttgtgggctcttttattgagctcggggagcagaagcgcgcgaacagaagcgagaagcgaactgattggttagttcaaataaggcacagggtcatttcaggtccttggggcaccctggaaacatctgatggttctctagaaactgctgagggcgggaccgcatctggggaccatctgttcttggccctgagccggggcaggaactgcttaccacagatatcctgtttggcccatattctgctgtctctctgttcctaaccttgatctgaacttctctattctcagttatgtattttccatgccttgcaaaatggcgttacttaagctagcttgccaaacctacaggtggggtctttcat
[0234] SEQ ID NO:86:
[0235] tgaagaataaaaaattactggcctcttgtgagaacatgaactttcacctcggagcccaccccctcccatctggaaaacatacttgagaaaaacattttctggaacaaccacagaatgtttcaacaggccagatgtattgccaaacacaggatatgactctttggttgagtaaatttgtggttgttaaacttcccctattccctccccattccccctcccagtttgtggttttttcctttaaaagcttgtgaaaaatttgagtcgtcgtcgagactcctctaccctgtgcaaaggtgtatgagtttcgaccccagagctctgtgtgctttctgttgctgctttatttcgaccccagagctctggtctgtgtgctttcatgtcgctgctttattaaatcttaccttctacattttatgtatggtctcagtgtcttcttgggtacgcggctgtcccgggacttgagtgtctgagtgagggtcttccctcgagggtctttcatttggtacatgggccgggaattcgagaatctttcatttggtgcattggccgggaattcgaaaatctttca
[0236] SEQ ID NO:87:
[0237] tgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggcgcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttca
[0238] SEQ ID NO:88
[0239] tgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcggggcgccagtcctccgattgactgagtcgcccgggtacccgtgtatccaataaaccctcttgcagttgcatccgacttgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccgtcagcgggggtctttca
[0240] SEQ ID NO:89:
[0241] ttgaaagaccccacccgtaggtggcaagctagcttaagtaacgccactttgcaaggcatggaaaaatacataactgagaatagaaaagttcagatcaaggtcaggaacaaagaaacagctgaataccaaacaggatatctgtggtaa gcggttcctgccccggctcagggccaagaacagatgagacagctgagtgatgggccaaacaggatatctgtggtaagcagttcctgccccggctcggggccaagaacagatggtccccagatgcggtccagccctcagcagtttcta gtgaatcatcagatgtttccagggtgccccaaggacctgaaaatgaccctgtaccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttccgctctccgagctcaataaaagagcccacaacccctcactcg gcgcgccagtcttccgatagactgcgtcgcccgggtacccgtattcccaataaagcctcttgctgtttgcatccgaatcgtggtctcgctgttccttgggagggtctcctctgagtgattgactacccacgggggtctttcatt
[0242] 2Wet test process module
[0243] Take 200ng gDNA installation kit HieffNGS OnePot Pro DNA Library Prep Kit for ILLUMINA for pre-library construction, the process mainly includes enzyme cutting and end repair, adding adapters and PCR amplification. Then take 500ng pre-library for liquid hybridization. Each hybridization system can hybridize up to 6 samples. Hybridization system and process use The Hybrid Capture Reagents v2 kit was used, and the process mainly included library hybridization, library capture and elution, hybrid capture library PCR amplification, and final library purification and quantification. The library was determined for fragment size (200-500bp with a main peak), and then pooled according to 3G data of each sample and sequenced on the machine (PE150).
[0244] 3. Experimental process module
[0245] The dry experiment analysis module mainly includes the following parts: according to the host source, the corresponding reference genome is downloaded from NCBI, and the LTR and ITR sequences of the probe are jointly designed to construct a comparison index; quality assessment and low-quality sequence removal are performed based on the original sequencing data after downloading the machine, and the sequencing reads after quality control are obtained, and then aligned to the host and the vector; reads that can be aligned to the vector and host genomes at the same time (i.e. softclip reads) are extracted to analyze the integration status, including integration sites, integration methods, etc.; then the integration ratio statistics are performed for the identified integration sites, and filtering is performed according to the set analysis threshold to finally obtain the integration site information. The analysis flow chart is as follows Figure 3 shown.
[0246] 4 Sample test result module
[0247] 4.1 Test Sample
[0248] (1) The test sample numbers are shown in Table 1.
[0249] Table 1 Test samples
[0250]
[0251] (2) Integration site information
[0252] WHO standard 18-144, 10 integration site information is shown in Table 2 below.
[0253] Table 2 WHO standard lentiviral integration sites (approximate sites)
[0254]
[0255] 4.2 Test Results
[0256] (1) Data quality control and comparison
[0257] After basic quality control of the data from the machine and removal of sequences with low sequencing quality, the statistical sample quality control results are shown in Table 3 below. The Splitreads ratio of the WHO standard is much higher than that of the negative sample, which is greater than 0.01.
[0258] Table 3 Test sample quality control results
[0259]
[0260] Note: Sample: sample number; RawReads: number of raw sequencing reads; CleanReads: number of reads after quality control; ReadsRatio (%): proportion of reads after quality control; Q20 (%): number of bases with sequencing quality value greater than 20; Q30 (%): number of bases with sequencing quality value greater than 30; GC (%): GC content; MapRatio (%): alignment ratio; DupRatio (%): duplication ratio; splitreads: number of reads that are aligned to both the host genome and LTR / ITR sequences, i.e., softclip (chimerism) occurs; splitreads ratio: ratio of softclip reads to reads after quality control.
[0261] (2) Integration analysis
[0262] Subsequently, the genome integration site detection and screening were performed based on Softclip reads, and the integration mode was determined based on the direction of each read alignment to the vector (LTR / ITR) and the host genome. If the alignment directions of the two are consistent (for example, both are "+" chains, or both are "-" chains), it means that the genome and the vector are forward integrated. If the alignment directions of the two are opposite (one is a "+" chain and the other is a "-" chain), it means that the genome and the vector are reversely integrated. The integration site information detection results are shown in Table 4 below.
[0263] Table 4 Integration site information detection results (example)
[0264]
[0265] Note: Read_ID: sequence ID; Cigar: alignment method; Vector_ID: vector ID; Vector_direct: the direction of sequence alignment to the vector (ITR / LTR) sequence; Vector_S: alignment to the starting site of the vector; Vector_E: alignment to the ending site of the vector; Host_ID: host chromosome ID; Host_direct: the direction of sequence alignment to the host sequence; Host_S: alignment to the starting site of the host; Host_E: alignment to the ending site of the host; Host_BP: integration site on the host genome.
[0266] (3) Integration ratio statistics
[0267] Based on the quality control results and integration analysis results, the integration site ratio information is obtained, including the number of supporting reads for each site, the proportion of supporting reads, and the normalized value of supporting reads. Table 5 below shows the detection site results of the 6 test samples.
[0268] Table 5 Integration ratio of detected sites
[0269]
[0270]
[0271]
[0272] Note: chr: host chromosome; pos: breakpoint on the host genome; supportreads: the number of support reads for the breakpoint; supportreads / splitreads: the ratio of the number of support reads for the breakpoint to the number of softclip reads for the sample; supportreads / cleanreads: the number of support reads for the breakpoint to the number of sequencing reads for the sample.
[0273] (4) Detection threshold setting
[0274] Finally, the detection rates of 10 positive sites in WHO samples and the detection results of negative samples were compared according to different combinations of supportreads / splitreads and supportreads / cleanreads, as shown in Figure 2. Figure 4 As shown in the figure, the final thresholds were set as: support reads / clean reads>5e-6, and support reads / split reads>0.01.
[0275] (5) Test results
[0276] a. 100% detection of 10 integration sites of WHO standard;
[0277] b. The conformity rate of negative sample detection results is 100% (none was detected).
[0278] The present invention innovatively proposes a strategy for realizing the detection of multiple viral vectors, provides a design idea for comprehensive integration site identification probes, as well as probe design sequences, to capture integration sites for different viral vectors, and is capable of comprehensively detecting the integration status of multiple viral delivery vector sequences with a detection accuracy rate of 100%.
[0279] The above are only preferred embodiments of the present invention. It should be pointed out that, for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A method for detecting viral integration sites, characterized in that: The steps include: Step 1, obtaining sample DNA and shearing it to a fragment with a main peak of 200 to 500 bp, and obtaining a pre-library after end repair, adding adapters and PCR amplification of the fragment; Step 2: obtaining the sequence of the viral delivery vector, obtaining a target sequence group after sequence truncation, alignment, removal of abnormal sequences and deduplication, and designing and synthesizing a probe group for detecting viral integration sites based on the target sequence group; Step 3, taking the pre-library and the probe set for liquid phase hybridization and then sequencing on a machine; Step 4: Compare the sequencing results with the host genome and the target sequence group respectively, and perform integration analysis, integration ratio statistics and detection threshold filtering based on the comparison results to obtain information on the virus integration site.
2. The detection method according to claim 1, characterized in that: In step 2, the sequence of the viral delivery vector includes the ITR sequence and / or LTR sequence of the viral delivery vector.
3. The detection method according to any one of claims 1 to 3, characterized in that: In the step 2, The sequence of the viral delivery vector is extracted using bedtools software according to the LTR and ITR position information in the feature information file; The sequences after sequence truncation were aligned using the mafft software and visualized based on MEGA to evaluate the conservation of the sequences and eliminate the abnormal sequences.
4. The detection method according to any one of claims 1 to 3, characterized in that: In step 3, the liquid phase hybridization includes library hybridization, library capture and elution to obtain a hybrid capture library, and the hybrid capture library is amplified by PCR, purified and quantified before sequencing on a machine; Preferably, in the liquid phase hybridization, the number of samples in the pre-library is an integer from 1 to 6.
5. The detection method according to any one of claims 1 to 4, characterized in that: In step 4, the results of the alignment include the number of reads after quality control, the number of breakpoint support reads of the target sequence group aligned, and the number of chimeric reads of the host genome and the target sequence group aligned simultaneously; The detection threshold is determined according to the following ① and / or ②: ①, the ratio of the number of breakpoint support reads to the number of reads after quality control; ②. The ratio of the number of breakpoint supporting reads to the number of chimeric reads.
6. The detection method according to any one of claims 1 to 5, characterized in that: The viral delivery vector comprises at least one of an adeno-associated viral delivery vector, a lentiviral delivery vector and a retroviral delivery vector; Preferably, the target sequence group includes at least one of the adeno-associated virus delivery vector target sequence group, the lentivirus delivery vector target sequence group and the retrovirus delivery vector target sequence group, wherein: The adeno-associated virus delivery vector target sequence group has at least one of the nucleotide sequences shown in SEQ ID NOs: 1 to 13; The lentiviral delivery vector target sequence group has at least one of the nucleotide sequences shown in SEQ ID NOs: 14 to 40; The target sequence group of the retroviral delivery vector has at least one of the nucleotide sequences shown in SEQ ID NOs: 41-89.
7. The detection method according to claim 6, characterized in that: The detection threshold is set as: The ratio of the number of breakpoint support reads to the number of reads after quality control is greater than 5e-6; and The ratio of the breakpoint supporting reads number to the chimeric reads number is greater than 0.
01.
8. An integration site detection device, characterized in that: include: Data acquisition module: used to obtain sample sequencing data; Analysis module: analyzing and obtaining viral integration sites according to the method described in any one of claims 1 to 7; Output module: used to output and display the results obtained by the analysis module.
9. A storage medium, characterized in that The storage medium includes a stored program, wherein the program, when executed by a processor, executes the method for detecting a virus integration site according to any one of claims 1 to 7.
10. An electronic device, characterized in that It comprises a processor, a memory and a bus, wherein the processor and the memory are connected via the bus; The memory is used to store programs, and the processor is used to run programs, wherein the program, when run by the processor, executes the method for detecting virus integration sites according to any one of claims 1 to 7.
